The following are excerpts from the newsletter

July 10, 2003

• Factors that contribute to errors with patient-controlled analgesia
• How to prevent certain kinds of errors with CPOE systems
• How new Florida legislation may encourage unsafe practices
• Errors associated with Fosamax (alendronate)
• Errors associated with acetaminophen
• Recent literature about how effectiveness of medication error-associated costs are in driving safety improvements

July 24, 2003

• How to prevent errors with patient-controlled analgesia (PCA)
• How color-coding products, such as cyclopentolate hydrochloride 1% solution and tropicamide 1% solution, can lead to medication errors
• How acetazolamide 500 mg vials by Ben Venue Laboratories is safer to use due to your reports
• How to avoid medication errors with FORADIL (formoterol fumerate